Table 4.
Variables | ORa univariate (95% CI) | P | ORa adjusted (95% CI) | P |
---|---|---|---|---|
Histology (ICD-O3) | ||||
Other Solid Tumors | 1 | 1 | ||
Hematological (C42, C77) | 2.40 (1.09–5.24) | .029 | 2.17 (0.96–4.90) | .062 |
Lung (C34) | 4.44 (1.56–12.57) | .005 | 4.05 (1.33–12.34) | .014 |
Sex | ||||
Female | 1 | 1 | ||
Male | 0.83 (0.46–1.49) | .539 | 0.88 (0.47–1.66) | .709 |
Age group | ||||
<60 | 1 | 1 | ||
≥60 | 2.44 (1.31–4.53) | .005 | 2.26 (1.18–4.35) | .014 |
Type of insurance | ||||
Public | 1 | - | - | |
Private | 0.83 (0.45–1.53) | .548 | - | - |
Situation at diagnosis of COVID-19 | ||||
In follow-up | 1 | - | - | |
In treatment | 2.38 (1.11–5.09) | .024 | 2.77 (1.25–6.13) | .011 |
Palliative | 19.01 (3.69–98.75) | .001 | 17.66 (3.13–99.59) | .001 |
Other Solid Tumors = (C50, C15-C17, C22-C26, C18-C21, C61, C64-C68, C30-C39, C51-C58, C49, C00-C14, C69-C72).
The values in bold are significant.
OR = Odds Ratio. Multivariable corrections were made for patient age and sex.